YAP1 and cancer: Rosenbluh and colleagues took a more targeted approach to inhibition of the Wnt pathway: they screened 85 cancer cell lines and found that β‐catenin active cancers are dependent on a signalling pathway involving the transcriptional regulator YAP1 (Yes‐associated protein 1) 28.